Detection of Mutated K12-ras in Histologically Negative Lymph Nodes as an Indicator of Poor Prognosis in Stage II Colorectal Cancer-Reference-Cited by-同舟云学术

Detection of Mutated K12-ras in Histologically Negative Lymph Nodes as an Indicator of Poor Prognosis in Stage II Colorectal Cancer

Published:2001-08 Issue:2 Volume:1 Page:110-116
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Belly Robert T.,Rosenblatt Joseph D.,Steinmann Michele,Toner Jacqueline,Sun Jianbo,Shehadi Joseph,Peacock James L.,Raubertas Richard F.,Jani Niraj,Ryan Charlotte K.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference19 articles.

1. Prevalence of ras gene mutations in human colorectal cancers;Bos;Nature,1987

2. Genetic alterations during colorectal-tumor development;Vogelstein;N Engl J Med,1988

3. Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study;Andreyev;J Natl Cancer Inst,1998

4. Micrometastasis in colorectal carcinoma: a review;Calaluce;J Surg Oncol,1998

5. Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators;Marsoni;Semin Oncol,2001

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of positive epidermal growth factor receptor expression and K-RAS gene mutations with various clinicopathological parameters and survival of colorectal carcinoma patients;Biomarkers and Genomic Medicine;2015-03

2. Markers of Sensitivity and Resistance to EGFR Inhibitors in Colorectal Cancer;Handbook of Therapeutic Biomarkers in Cancer;2013-06-12

3. EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma;INT J MOL SCI;2013

4. Prognostic and survival analysis of 837 Chinese colorectal cancer patients;World Journal of Gastroenterology;2013

5. Prognostic and predictive biomarkers for epidermal growth factor receptor-targeted therapy in colorectal cancer: Beyond KRAS mutations;Critical Reviews in Oncology/Hematology;2013-01